My HPRA: Register

HALDOL DECANOATE

50 Mg/Ml Solution for Injection

Janssen-Cilag LtdPA0748/021/001

SPC: MARKETING AUTHORISATION NUMBER

19 May 2015 - 23 Jun 2017	23 Jun 2017 - Present
PA 748/21/1	PA0748/021/001

« Back

Follow medicine

Print

Latest Changes to Medicine Info & SPC

23 Jun 2017
SPC: DATE OF REVISION OF THE TEXT
23 Jun 2017
SPC: MARKETING AUTHORISATION NUMBER
23 Jun 2017
SPC: MARKETING AUTHORISATION HOLDER
23 Jun 2017
SPC: Special precautions for disposal of a used medicinal product or waste materials derived from such medicinal product and other handling of the product
23 Jun 2017
SPC: Preclinical safety data
23 Jun 2017
SPC: Pharmacokinetic properties
23 Jun 2017
SPC: Pharmacodynamic properties
23 Jun 2017
SPC: Overdose
23 Jun 2017
SPC: Undesirable effects
23 Jun 2017
SPC: Effects on ability to drive and use machines
23 Jun 2017
SPC: Fertility, pregnancy and lactation
23 Jun 2017
SPC: Interaction with other medicinal products and other forms of interaction
23 Jun 2017
SPC: Special warnings and precautions for use
23 Jun 2017
SPC: Contraindications
23 Jun 2017
SPC: Posology and method of administration
23 Jun 2017
SPC: Therapeutic Indications
23 Jun 2017
SPC: PHARMACEUTICAL FORM
23 Jun 2017
SPC: QUALITATIVE AND QUANTITATIVE COMPOSITION
25 Aug 2015
ATC Code(s)

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.

Important information regarding cookies and the HPRA

By using this website, you consent to the use of cookies in accordance with the HPRA Cookie Policy.
For more information on cookies, see our cookie policy.

Click here to accept the cookie policy and hide this message